Singapore markets closed

Phibro Animal Health Corporation (PAHC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.70-0.08 (-0.48%)
At close: 04:00PM EDT
16.65 -0.05 (-0.30%)
After hours: 07:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 679.65M
Enterprise value 1.10B
Trailing P/E 45.35
Forward P/E 13.53
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.69
Price/book (mrq)2.51
Enterprise value/revenue 1.12
Enterprise value/EBITDA 13.15

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 37.05%
S&P500 52-week change 323.10%
52-week high 316.90
52-week low 39.40
50-day moving average 313.00
200-day moving average 312.49

Share statistics

Avg vol (3-month) 3160.11k
Avg vol (10-day) 3205.27k
Shares outstanding 520.34M
Implied shares outstanding 640.5M
Float 820.21M
% held by insiders 10.63%
% held by institutions 1103.52%
Shares short (15 Apr 2024) 4626.54k
Short ratio (15 Apr 2024) 44.82
Short % of float (15 Apr 2024) 45.15%
Short % of shares outstanding (15 Apr 2024) 41.55%
Shares short (prior month 15 Mar 2024) 4855.84k

Dividends & splits

Forward annual dividend rate 40.48
Forward annual dividend yield 42.86%
Trailing annual dividend rate 30.48
Trailing annual dividend yield 32.86%
5-year average dividend yield 42.63
Payout ratio 4129.73%
Dividend date 327 Mar 2024
Ex-dividend date 405 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1.51%
Operating margin (ttm)6.41%

Management effectiveness

Return on assets (ttm)3.72%
Return on equity (ttm)5.49%

Income statement

Revenue (ttm)982.01M
Revenue per share (ttm)24.25
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 90.99M
Net income avi to common (ttm)14.8M
Diluted EPS (ttm)0.37
Quarterly earnings growth (yoy)-82.30%

Balance sheet

Total cash (mrq)104.84M
Total cash per share (mrq)2.59
Total debt (mrq)513.09M
Total debt/equity (mrq)189.47%
Current ratio (mrq)3.12
Book value per share (mrq)6.69

Cash flow statement

Operating cash flow (ttm)74.25M
Levered free cash flow (ttm)38.29M